c2pred – C2 Pharma

FINANCIAL TIMES GLOBAL PHARMACEUTICAL AND BIOTECHNOLOGY CONFERENCE

Posted on 22. November 201823. February 2021 by c2pred

C² PHARMA and ANKLAM EXTRAKT® announce R&D collaboration

Posted on 5. October 201820. March 2019 by c2pred

Validation

Posted on 4. October 20184. October 2018 by c2pred

C2 PHARMA leads

Posted on 4. October 201823. February 2021 by c2pred

C² PHARMA brings reliable cannabidiol (cbd) api source to pharma companies and expands its r&d product pipeline

Posted on 2. October 20182. October 2018 by c2pred

CPhI 2017: C² PHARMA acquires R&D synthesis services company and establishes cold-chain logistics spin-off

Posted on 16. October 201723. February 2021 by c2pred

Centroflora CMS changes its name to C² PHARMA

Posted on 4. October 201723. February 2021 by c2pred

CEP approval

Posted on 2. October 201723. February 2021 by c2pred

CPhI Award nomination

Posted on 20. September 201726. September 2018 by c2pred

Information Brief

Posted on 5. September 201725. September 2018 by c2pred

Finalist

Posted on 19. September 201612. January 2021 by c2pred

INFORMATION BRIEF

Posted on 9. September 201625. September 2018 by c2pred

Winner

Posted on 27. October 201512. January 2021 by c2pred

Major expansion

Posted on 4. October 201526. September 2018 by c2pred

Finalist

Posted on 21. September 201512. January 2021 by c2pred

Brazilian Pavillion

Posted on 1. September 201525. September 2018 by c2pred

Award

Posted on 22. May 201512. January 2021 by c2pred

CHEMICAL & ENGINEERING NEWS

Posted on 16. March 201512. January 2021 by c2pred

Paris

Posted on 1. September 201425. September 2018 by c2pred